V

Varian

Tech-enabled radiation oncology hardware and software

Professional Services Executive

Full-TimeUpdated
$99.5k - $142k
Senior
Bachelor's, Master's
Winnipeg, MB, Canada+3 moreMore locations: Ontario, Canada | Calgary, AB, Canada | Halifax Regional Municipality, NS, Canada
RemoteRemote roles; travel required 50%-75%.
Customer Experience & SupportCustomer Success

About the job

Requirements
  • Ability, competence, and confidence to lead people.
  • Effective interpersonal skills.
  • Proficiency with email, Microsoft Word, Excel, and PowerPoint.
  • Experience with a human capital management system such as Workday, or an equivalent enterprise resource planning product and productivity software.
  • Experience with Salesforce customer relationship management.
  • Strong problem-solving abilities.
  • Ability to plan and manage numerous processes, people, and projects simultaneously.
  • Communication, collaboration, and delegation skills.
  • Organizational acumen and skills.
  • Executive presence.
  • Responsiveness and reliability.
  • Presentation skills.
  • Selling skills.
  • A minimum of seven years of managerial experience in healthcare administration with expertise in oncology operations, such as radiation oncology or medical oncology.
  • Demonstrated leadership experience in clinical operations driving strategic and business planning, financial and operational performance.
  • Organizational, analytical, and communication skills with a proven track record of collaboration and consensus-building.
  • Completion of the learning management system training plan specific to assigned responsibility.
  • Proficiency with email, Microsoft Word, Excel, and PowerPoint.
  • Knowledge of quality, performance improvement, change theory, and health systems.
  • Basic information technology knowledge, especially interoperability and infrastructure.
  • Full client-site access and completion and ongoing fulfillment of applicable vendor credentialing requirements, unless prohibited by law; requirements may include valid identification, criminal background checks, drug screens, immunizations, annual tuberculosis testing, and healthcare training.
Responsibilities
  • Oversee the execution team and ensure client strategic goals are achieved through Varian's end-to-end solution as defined by the scope of work.
  • Build and maintain collaborative, executive-level partnerships that support long-term loyalty.
  • Partner with Oncology Solutions Managers, Sales, and other Varian leadership to ensure client success from strategy scoping through execution.
  • Execute enterprise solutions focused on reducing time to value for partners.
  • Act as a Varian product and oncology expert to assist with client success as defined by the scope of work.
  • Operationalize the execution plan, key performance indicators for routine performance scorecards, and partnership governance structures based on each client's scope of work.
  • Ensure program deliverables are patient-centered end-to-end solutions that put patients first, close consumption gaps, and shift strategy toward diversified recurring revenue.
  • Achieve assigned key success outcome targets; build client relationships; ensure long-term client loyalty; execute Varian implementation processes; ensure client satisfaction; and represent the company effectively.
  • Represent Varian ethics, values, and business practices with internal and external constituents.
  • Oversee the project and supporting resources through a dotted-line reporting structure.
Desired Qualifications
  • Clinical background, such as registered radiation therapist, registered nurse, medical oncology, certified medical dosimetrist, or PhD.
  • Master's degree, such as an MBA or MHA.
  • Passion for client service and relationship building.
  • Strategic and relevant knowledge and cross-functional experience, including Varian solutions, oncology operations, and oncology business.
  • Understanding of different business models and ability to bring together complex technologies to create value for partners.
  • Ability to advocate internally and translate for partners, and to promote Varian externally.
  • Ability to work in matrixed and unstructured environments.
  • Multimode communication skills for communicating with all levels in both organizations.
  • Ability to synthesize quickly and translate between both organizations.
  • Organizational and analytical skills with a proven track record of collaboration and consensus-building.
  • Healthcare finance knowledge, including basic organizational profit and loss.
  • Ability to lead through influence.
  • Experience with SAP or an equivalent enterprise resource planning product and productivity software.

About the company

Varian, part of Siemens Healthineers, focuses on oncology by providing integrated radiation oncology solutions that combine software, hardware, patient data, and care teams. Its offerings include treatment-planning software, radiation therapy machines, and data-management systems that work together to enable precise cancer treatments. The company differentiates itself through an integrated platform approach and services like Oncology-as-a-Service (OaaS), which lets healthcare providers adopt advanced radiation oncology with ongoing service support rather than large upfront investments. Varian serves healthcare providers such as hospitals and cancer centers, helping them deliver coordinated care and improve patient outcomes. Its goal is to reduce the fear of cancer by using data and technology to support clinicians in delivering effective treatments.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Palo Alto, California

Founded

1948

Get referred to Varian

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ARPA-H awarded Varian up to $60 million in April 2026 for FLASH-RT.
  • FDA cleared TrueBeam for osteoarthritis in March 2026, opening a non-cancer market.
  • Telix collaboration and 2026 AI approvals expand Varian's clinical and software pipeline.

What critics are saying

  • RaySearch enabled online adaptive TrueBeam workflows in Belgium in May 2026, eroding software differentiation.
  • Elekta still attacks Varian's lead in adaptive radiotherapy and premium MR-guided care.
  • If FLASH and non-oncology bets fail by 2028, Varian becomes a commoditized linear-accelerator vendor.

What makes Varian unique

  • Siemens Healthineers gives Varian imaging, radiotherapy, and capital-sales integration globally.
  • Varian's 2026 CE-marked Eclipse AI contouring deepens workflow lock-in across planning.
  • TrueBeam, Halcyon, and Ethos create an installed-base moat hospitals rarely replace.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours
  • Remote Work Options
  • Paid Vacation
  • Paid Holidays
  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Wellness Program
  • 401(k) Retirement Plan

Growth & Insights and Company News

6 month growth

3%

1 year growth

3%

2 year growth

3%
Varex Imaging Corporation
Sep 14th, 2026
About Us | Varex Imaging Corporation

We strive to help customers become world-class system suppliers by strengthening their competitiveness and enabling them to bring products to market faster

MEDQOR
Apr 30th, 2026
Siemens Healthineers secures $83M to develop photon Flash radiotherapy for cancer treatment

Siemens Healthineers has received up to $60 million from the US Advanced Research Projects Agency for Health to develop photon Flash radiotherapy, with the company contributing an additional $23 million, totalling $83 million over five years. Flash photon therapy delivers radiotherapy more than 100 times faster than current technologies, aiming to reduce side effects and improve healthy tissue sparing. Unlike proton and electron beam platforms, which face scalability challenges, photon beams are the standard of care for over 50% of cancer patients. The project will build on existing C-arm linear accelerators to enable broader clinical access. Siemens Healthineers aims to transition ultra-high dose rate radiotherapy from experimental treatment into global standard of care within the five-year timeframe.

Business Wire
Mar 19th, 2026
Varian TrueBeam gets FDA clearance for low-dose radiotherapy to treat osteoarthritis

Siemens Healthineers has received FDA 510(k) clearance for its Varian TrueBeam radiotherapy systems to treat medically refractory osteoarthritis in adults using low-dose radiation therapy. This marks the first expansion of Varian's radiotherapy platform beyond cancer care into chronic musculoskeletal conditions. Osteoarthritis affects over 33 million adults in the US and approximately 600 million globally. The clearance covers TrueBeam, TrueBeam STx, VitalBeam and Edge systems, offering patients with persistent pain a non-invasive outpatient treatment option that targets inflammation, reduces pain and improves joint function. The approval builds on Varian's previous regulatory clearances for non-oncological indications, including radiosurgery treatment for medically refractory essential tremor. The TrueBeam platform combines high-resolution imaging with precise dose control whilst maintaining streamlined clinical workflows.

AuntMinnieEurope.com
Dec 10th, 2025
Telix and Varian enter research collaboration

Telix and Varian enter research collaboration. Telix Pharmaceuticals and Siemens Healthineers' company Varian have agreed to develop novel clinical applications that combine Telix's theranostics products and Varian's external beam radiation therapy (EBRT) technology. The first area of focus will be in identifying opportunities to use Telix's prostate cancer PET imaging agents in selecting patients for EBRT, developing personalized treatment plans (particularly in the context of Varian's Ethos adaptive radiotherapy system), and monitoring responses to treatment, Telix said. The agreement supports both company-sponsored and investigator-led clinical studies. Varian is a key player in EBRT and working with the company will allow Telix to explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment, Telix noted. I agree to receive marketing related digital communications about products, services, events and offers that may be relevant to my given user preferences and behavior. I agree to share my information with the sponsor. I have read and agree to the privacy policy & terms of service and wish to opt-in.

AuntMinnie.com
Mar 28th, 2025
Varian, Embolx sign image-guided microcatheter agreement

Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter.